Published in J Mater Sci Mater Med on December 12, 2012
Synthesis and characterization of cerium- and gallium-containing borate bioactive glass scaffolds for bone tissue engineering. J Mater Sci Mater Med (2015) 0.77
Solutions able to reproduce in vivo surface-structure changes in bioactive glass-ceramic A-W. J Biomed Mater Res (1990) 7.05
Calcium phosphates in oral biology and medicine. Monogr Oral Sci (1991) 2.58
The story of Bioglass. J Mater Sci Mater Med (2006) 2.53
Amorphous calcium phosphate is a major component of the forming fin bones of zebrafish: Indications for an amorphous precursor phase. Proc Natl Acad Sci U S A (2008) 2.41
Characterization of hydroxyapatite and carbonated apatite by photo acoustic FTIR spectroscopy. J Mater Sci Mater Med (1997) 2.28
Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass 45S5 dissolution. J Biomed Mater Res (2001) 2.24
Bioactive glass in tissue engineering. Acta Biomater (2011) 2.23
Intermediate states in the precipitation of hydroxyapatite. Nature (1965) 1.84
Effect of bioactive glass particle size on osseous regeneration of cancellous defects. J Biomed Mater Res (1998) 1.65
Solution effects on the surface reactions of a bioactive glass. J Biomed Mater Res (1993) 1.36
Kinetics and mechanisms of the conversion of silicate (45S5), borate, and borosilicate glasses to hydroxyapatite in dilute phosphate solutions. J Mater Sci Mater Med (2006) 1.35
Amorphous calcium (ortho)phosphates. Acta Biomater (2010) 1.33
Effect of bioactive glasses on angiogenesis: a review of in vitro and in vivo evidences. Tissue Eng Part B Rev (2010) 1.29
Silicate, borosilicate, and borate bioactive glass scaffolds with controllable degradation rate for bone tissue engineering applications. I. Preparation and in vitro degradation. J Biomed Mater Res A (2010) 1.23
Phosphate glasses for tissue engineering: Part 1. Processing and characterisation of a ternary-based P2O5-CaO-Na2O glass system. Biomaterials (2004) 1.18
Calcium: a potential central regulator in wound healing in the skin. Wound Repair Regen (2002) 1.18
Infra-red determinaion of the percentage of crystallinity in apatitic calcium phosphates. Nature (1966) 1.18
The effects of calcium alginate on wound healing. Ann R Coll Surg Engl (1987) 1.11
An electron microscopic study of the formation of amorphous calcium phosphate and its transformation to crystalline apatite. Calcif Tissue Res (1973) 1.10
Measurements of the solubilities and dissolution rates of several hydroxyapatites. Biomaterials (2002) 1.09
In vitro/in vivo biocompatibility and mechanical properties of bioactive glass nanofiber and poly(epsilon-caprolactone) composite materials. J Biomed Mater Res B Appl Biomater (2009) 1.08
Bioactive borosilicate glass scaffolds: in vitro degradation and bioactivity behaviors. J Mater Sci Mater Med (2009) 0.91
The influence of carbonate on the atomic structure and reactivity of hydroxyapatite. J Dent Res (1981) 0.87
Fabrication and in vitro biomineralization of bioactive glass (BG) nanofibres. Nanotechnology (2007) 0.80
Reaction of sodium calcium borate glasses to form hydroxyapatite. J Mater Sci Mater Med (2007) 0.80
Bioactive glass in tissue engineering. Acta Biomater (2011) 2.23
Kinetics and mechanisms of the conversion of silicate (45S5), borate, and borosilicate glasses to hydroxyapatite in dilute phosphate solutions. J Mater Sci Mater Med (2006) 1.35
Mechanical and in vitro performance of 13-93 bioactive glass scaffolds prepared by a polymer foam replication technique. Acta Biomater (2008) 1.27
Freeze casting of porous hydroxyapatite scaffolds. I. Processing and general microstructure. J Biomed Mater Res B Appl Biomater (2008) 1.24
Silicate, borosilicate, and borate bioactive glass scaffolds with controllable degradation rate for bone tissue engineering applications. I. Preparation and in vitro degradation. J Biomed Mater Res A (2010) 1.23
Bioactive glass scaffolds for bone tissue engineering: state of the art and future perspectives. Mater Sci Eng C Mater Biol Appl (2011) 1.18
Fabrication and testing of silicon nitride bearings in total hip arthroplasty: winner of the 2007 "HAP" PAUL Award. J Arthroplasty (2008) 1.06
Preparation of hollow hydroxyapatite microspheres. J Mater Sci Mater Med (2006) 1.03
Freeze casting of porous hydroxyapatite scaffolds. II. Sintering, microstructure, and mechanical behavior. J Biomed Mater Res B Appl Biomater (2008) 1.03
Preparation and properties of porous microspheres made from borate glass. J Biomed Mater Res A (2009) 1.02
Silicate, borosilicate, and borate bioactive glass scaffolds with controllable degradation rate for bone tissue engineering applications. II. In vitro and in vivo biological evaluation. J Biomed Mater Res A (2010) 1.00
Effect of Process Variables on the Microstructure of Hollow Hydroxyapatite Microspheres Prepared by a Glass Conversion Method. J Am Ceram Soc (2010) 0.99
Growth and differentiation of osteoblastic cells on 13-93 bioactive glass fibers and scaffolds. Acta Biomater (2007) 0.96
Effect of borate glass composition on its conversion to hydroxyapatite and on the proliferation of MC3T3-E1 cells. J Biomed Mater Res A (2009) 0.96
Preparation and in vitro evaluation of bioactive glass (13-93) scaffolds with oriented microstructures for repair and regeneration of load-bearing bones. J Biomed Mater Res A (2010) 0.95
The significance of metal staining on alumina femoral heads in total hip arthroplasty. J Arthroplasty (2007) 0.95
Novel borate glass/chitosan composite as a delivery vehicle for teicoplanin in the treatment of chronic osteomyelitis. Acta Biomater (2009) 0.93
Teicoplanin-loaded borate bioactive glass implants for treating chronic bone infection in a rabbit tibia osteomyelitis model. Biomaterials (2010) 0.92
In vivo outcomes of tissue-engineered osteochondral grafts. J Biomed Mater Res B Appl Biomater (2010) 0.90
Strength of hollow hydroxyapatite microspheres prepared by a glass conversion process. J Mater Sci Mater Med (2008) 0.90
Freeze extrusion fabrication of 13-93 bioactive glass scaffolds for bone repair. J Mater Sci Mater Med (2011) 0.89
Hollow hydroxyapatite microspheres as a device for controlled delivery of proteins. J Mater Sci Mater Med (2011) 0.89
Freeze-cast hydroxyapatite scaffolds for bone tissue engineering applications. Biomed Mater (2008) 0.89
Porous and strong bioactive glass (13-93) scaffolds prepared by unidirectional freezing of camphene-based suspensions. Acta Biomater (2011) 0.89
Bone regeneration in strong porous bioactive glass (13-93) scaffolds with an oriented microstructure implanted in rat calvarial defects. Acta Biomater (2012) 0.88
In vivo evaluation of 13-93 bioactive glass scaffolds with trabecular and oriented microstructures in a subcutaneous rat implantation model. J Biomed Mater Res A (2010) 0.87
Preparation and bioactive characteristics of a porous 13-93 glass, and fabrication into the articulating surface of a proximal tibia. J Biomed Mater Res A (2007) 0.87
Mechanical properties of bioactive glass (13-93) scaffolds fabricated by robotic deposition for structural bone repair. Acta Biomater (2013) 0.87
Oriented bioactive glass (13-93) scaffolds with controllable pore size by unidirectional freezing of camphene-based suspensions: Microstructure and mechanical response. Acta Biomater (2010) 0.86
Bone regeneration in rat calvarial defects implanted with fibrous scaffolds composed of a mixture of silicate and borate bioactive glasses. Acta Biomater (2013) 0.86
Hollow hydroxyapatite microspheres: a novel bioactive and osteoconductive carrier for controlled release of bone morphogenetic protein-2 in bone regeneration. Acta Biomater (2013) 0.84
Evaluation of bone regeneration in implants composed of hollow HA microspheres loaded with transforming growth factor β1 in a rat calvarial defect model. Acta Biomater (2012) 0.83
Bioactive borate glass scaffolds: in vitro and in vivo evaluation for use as a drug delivery system in the treatment of bone infection. J Mater Sci Mater Med (2009) 0.83
Robotic deposition and in vitro characterization of 3D gelatin-bioactive glass hybrid scaffolds for biomedical applications. J Biomed Mater Res A (2012) 0.82
A unified in vitro evaluation for apatite-forming ability of bioactive glasses and their variants. J Mater Sci Mater Med (2015) 0.82
In vitro and in vivo dissolution behavior of a dysprosium lithium borate glass designed for the radiation synovectomy treatment of rheumatoid arthritis. J Biomed Mater Res (2002) 0.81
Enhanced bone regeneration in rat calvarial defects implanted with surface-modified and BMP-loaded bioactive glass (13-93) scaffolds. Acta Biomater (2013) 0.81
In vitro study on different cell response to spherical hydroxyapatite nanoparticles. J Biomater Appl (2008) 0.81
Native nucleus pulposus tissue matrix promotes notochordal differentiation of human induced pluripotent stem cells with potential for treating intervertebral disc degeneration. J Biomed Mater Res A (2014) 0.81
A novel injectable borate bioactive glass cement for local delivery of vancomycin to cure osteomyelitis and regenerate bone. J Mater Sci Mater Med (2014) 0.81
Effect of bioactive borate glass microstructure on bone regeneration, angiogenesis, and hydroxyapatite conversion in a rat calvarial defect model. Acta Biomater (2013) 0.80
Reaction of sodium calcium borate glasses to form hydroxyapatite. J Mater Sci Mater Med (2007) 0.80
Three-dimensional visualization of bioactive glass-bone integration in a rabbit tibia model using synchrotron X-ray microcomputed tomography. Tissue Eng Part A (2011) 0.79
Comparison of the response of primary human blood monocytes and the U937 human monocytic cell line to two different sizes of alumina ceramic particles. J Orthop Res (2004) 0.78
Biodegradable radiation delivery system utilizing glass microspheres and ethylenediaminetetraacetate chelation therapy. J Biomed Mater Res A (2004) 0.78
Evaluation of BSA protein release from hollow hydroxyapatite microspheres into PEG hydrogel. Mater Sci Eng C Mater Biol Appl (2013) 0.78
In vitro bioactivity, cytocompatibility, and antibiotic release profile of gentamicin sulfate-loaded borate bioactive glass/chitosan composites. J Mater Sci Mater Med (2013) 0.78
In vitro performance of 13-93 bioactive glass fiber and trabecular scaffolds with MLO-A5 osteogenic cells. J Biomed Mater Res A (2012) 0.77
Elution characteristics of teicoplanin-loaded biodegradable borate glass/chitosan composite. Int J Pharm (2009) 0.77
Evaluation of borate bioactive glass scaffolds with different pore sizes in a rat subcutaneous implantation model. J Biomater Appl (2012) 0.77
Angiogenic effects of borate glass microfibers in a rodent model. J Biomed Mater Res A (2014) 0.76
Evaluation of injectable strontium-containing borate bioactive glass cement with enhanced osteogenic capacity in a critical-sized rabbit femoral condyle defect model. ACS Appl Mater Interfaces (2015) 0.76
In vitro evaluation of cytotoxicity of silver-containing borate bioactive glass. J Biomed Mater Res B Appl Biomater (2010) 0.76
Conversion of borate-based glass scaffold to hydroxyapatite in a dilute phosphate solution. Biomed Mater (2010) 0.76
Testing of silicon nitride ceramic bearings for total hip arthroplasty. J Biomed Mater Res B Appl Biomater (2008) 0.76
Mechanism for converting Al2O3-containing borate glass to hydroxyapatite in aqueous phosphate solution. Acta Biomater (2008) 0.76
Effect of pyrophosphate ions on the conversion of calcium-lithium-borate glass to hydroxyapatite in aqueous phosphate solution. J Mater Sci Mater Med (2010) 0.75
Preparation and in vitro characterization of electrospun PVA scaffolds coated with bioactive glass for bone regeneration. J Biomed Mater Res A (2012) 0.75
Estimation of properties of a photoinitiated silorane-based composite with potential for orthopaedic applications. J Biomed Mater Res B Appl Biomater (2011) 0.75
Cytotoxicity assessment of modified bioactive glasses with MLO-A5 osteogenic cells in vitro. J Mater Sci Mater Med (2013) 0.75
Long-term conversion of 45S5 bioactive glass-ceramic microspheres in aqueous phosphate solution. J Mater Sci Mater Med (2012) 0.75
Proliferation and function of MC3T3-E1 cells on freeze-cast hydroxyapatite scaffolds with oriented pore architectures. J Mater Sci Mater Med (2008) 0.75